Zomig Rapimelt is contraindicated in patients with: Known hypersensitivity to any component of the product.
Uncontrolled hypertension.
Ischaemic heart disease.
Coronary vasospasm/Prinzmetal's angina.
A history of cerebrovascular accident (CVA) or transient ischaemic attack (TIA).
Concomitant administration of Zomig Rapimelt with ergotamine or ergotamine derivatives or other 5-HT1 receptor agonists.